ClearPoint Neuro (CLPT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.07, -5.91% vs the prior close of $9.64.
- Volume 965.01K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CLPT slides 5.9% to $9.07, a 6-month low. Closed at $9.07, -5.91% vs the prior close of $9.64. Day range $9.00–$9.60, opened at $9.58.
CLPT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CLPT slides 5.9% to $9.07, a 6-month low
- Closed at $9.07, -5.91% vs the prior close of $9.64. Day range $9.00–$9.60, opened at $9.58.
- Volume was 965.01K shares, 1.5x its 50-day average of 642.05K.
- Price is -33.3% vs its 50-day average ($13.60) and -31.4% vs its 200-day average ($13.22).
- 52-week range $8.27–$28.10; today's close sits at 4% of that range, 67.7% below the 52-week high.
Oct 15, 2026 — CLPT jumps 4.3% to $9.64
- Closed at $9.64, +4.33% vs the prior close of $9.24. Day range $9.10–$9.68, opened at $9.11.
- Volume was 797.60K shares, 1.2x its 50-day average of 638.65K.
- Price is -29.5% vs its 50-day average ($13.68) and -27.2% vs its 200-day average ($13.24).
- 52-week range $8.27–$28.10; today's close sits at 7% of that range, 65.7% below the 52-week high.
Oct 14, 2026 — CLPT slides 5.8% to $9.24, a 6-month low, 7 down days in a row
- Closed at $9.24, -5.81% vs the prior close of $9.81. Day range $9.19–$9.80, opened at $9.68.
- Volume was 1.01M shares, 1.5x its 50-day average of 676.24K.
- Price is -32.8% vs its 50-day average ($13.75) and -30.3% vs its 200-day average ($13.26).
- 52-week range $8.27–$28.10; today's close sits at 5% of that range, 67.1% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — CLPT slides 3.8% to $9.81, a 6-month low, 6 down days in a row
- Closed at $9.81, -3.82% vs the prior close of $10.20. Day range $9.72–$10.17, opened at $10.17.
- Volume was 792.30K shares, 1.2x its 50-day average of 675.34K.
- Price is -29.0% vs its 50-day average ($13.83) and -26.2% vs its 200-day average ($13.29).
- 52-week range $8.27–$28.10; today's close sits at 8% of that range, 65.1% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — CLPT dips 2.7% to $10.20, a 3-month low, 5 down days in a row
- Closed at $10.20, -2.67% vs the prior close of $10.48. Day range $10.12–$10.51, opened at $10.37.
- Volume was 397.60K shares, 0.6x its 50-day average of 679.50K — lighter than usual.
- Price is -26.8% vs its 50-day average ($13.94) and -23.4% vs its 200-day average ($13.31).
- 52-week range $8.27–$29.35; today's close sits at 9% of that range, 65.2% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — CLPT ends flat (-0.1%) to $10.48, a 3-month low, 4 down days in a row
- Closed at $10.48, -0.10% vs the prior close of $10.49. Day range $10.22–$10.60, opened at $10.45.
- Volume was 409.50K shares, 0.6x its 50-day average of 680.08K.
- Price is -25.3% vs its 50-day average ($14.03) and -21.4% vs its 200-day average ($13.33).
- 52-week range $8.27–$30.10; today's close sits at 10% of that range, 65.2% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — CLPT dips 1.6% to $10.49, a 3-month low, 3 down days in a row
- Closed at $10.49, -1.59% vs the prior close of $10.66. Day range $10.18–$10.56, opened at $10.56.
- Volume was 717.90K shares, 1.1x its 50-day average of 676.24K.
- Price is -25.7% vs its 50-day average ($14.11) and -21.4% vs its 200-day average ($13.35).
- 52-week range $8.27–$30.10; today's close sits at 10% of that range, 65.1% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CLPT slides 3.2% to $10.66, a 3-month low
- Closed at $10.66, -3.18% vs the prior close of $11.01. Day range $10.58–$10.98, opened at $10.85.
- Volume was 490.10K shares, 0.7x its 50-day average of 679.72K.
- Price is -24.9% vs its 50-day average ($14.19) and -20.3% vs its 200-day average ($13.37).
- 52-week range $8.27–$30.10; today's close sits at 11% of that range, 64.6% below the 52-week high.
Oct 6, 2026 — CLPT slides 4.4% to $11.01
- Closed at $11.01, -4.43% vs the prior close of $11.52. Day range $10.63–$11.74, opened at $11.60.
- Volume was 903.50K shares, 1.4x its 50-day average of 668.14K.
- Price is -22.8% vs its 50-day average ($14.26) and -17.7% vs its 200-day average ($13.38).
- 52-week range $8.27–$30.10; today's close sits at 13% of that range, 63.4% below the 52-week high.
Oct 5, 2026 — CLPT jumps 5.7% to $11.52
- Closed at $11.52, +5.69% vs the prior close of $10.90. Day range $10.61–$11.53, opened at $10.85.
- Volume was 760.00K shares, 1.1x its 50-day average of 662.28K.
- Price is -19.6% vs its 50-day average ($14.34) and -14.0% vs its 200-day average ($13.40).
- 52-week range $8.27–$30.10; today's close sits at 15% of that range, 61.7% below the 52-week high.
Oct 2, 2026 — CLPT slides 4.8% to $10.90, a 3-month low
- Closed at $10.90, -4.80% vs the prior close of $11.45. Day range $10.85–$11.58, opened at $11.58.
- Volume was 831.50K shares, 1.3x its 50-day average of 661.35K.
- Price is -24.2% vs its 50-day average ($14.39) and -18.7% vs its 200-day average ($13.41).
- 52-week range $8.27–$30.10; today's close sits at 12% of that range, 63.8% below the 52-week high.
CLPT latest news & SEC filings
Every SEC filing by or about CLPT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Richards Timothy T. received an award of 319 shares at $12.21 (≈$3.89K) on Oct 1, 2026; now holds 87,863
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fletcher R John received an award of 993 shares at $12.21 (≈$12.12K) on Oct 1, 2026; now holds 132,004
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $10.88M (prior year $9.21M) (+18.1% vs Jun 30, 2025)
- Net income: -$11.34M (prior year -$5.84M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.38 (prior year -$0.21) (loss widened vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade CLPT
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 17, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.09% (largest 23.1%). That is a volatile stock.
- Liquidity: about 817.40K shares (≈$7.41M) trade per day on average.
- 52-week position: $9.07 vs a range of $8.27–$28.10 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Joseph Burnett sold 20,000 shares on Jun 29, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K May 21, 2026.
- Share count: 30.50M shares outstanding (Jul 27, 2026), +7.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
CLPT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.58 | 9.60 | 9.00 | 9.07 | 965.01K |
| Oct 15, 2026 | 9.11 | 9.68 | 9.10 | 9.64 | 797.60K |
| Oct 14, 2026 | 9.68 | 9.80 | 9.19 | 9.24 | 1.01M |
| Oct 13, 2026 | 10.17 | 10.17 | 9.72 | 9.81 | 792.30K |
| Oct 12, 2026 | 10.37 | 10.51 | 10.12 | 10.20 | 397.60K |
| Oct 9, 2026 | 10.45 | 10.60 | 10.22 | 10.48 | 409.50K |
| Oct 8, 2026 | 10.56 | 10.56 | 10.18 | 10.49 | 717.90K |
| Oct 7, 2026 | 10.85 | 10.98 | 10.58 | 10.66 | 490.10K |
| Oct 6, 2026 | 11.60 | 11.74 | 10.63 | 11.01 | 903.50K |
| Oct 5, 2026 | 10.85 | 11.53 | 10.61 | 11.52 | 760.00K |
| Oct 2, 2026 | 11.58 | 11.58 | 10.85 | 10.90 | 831.50K |
| Oct 1, 2026 | 12.24 | 12.24 | 11.40 | 11.45 | 765.90K |
| Sep 30, 2026 | 11.85 | 12.54 | 11.54 | 12.21 | 1.25M |
| Sep 29, 2026 | 12.63 | 12.99 | 11.60 | 11.77 | 2.69M |
| Sep 28, 2026 | 14.64 | 15.42 | 14.24 | 15.31 | 476.20K |
| Sep 25, 2026 | 14.77 | 15.12 | 14.36 | 14.83 | 321.30K |
| Sep 24, 2026 | 14.82 | 14.90 | 14.23 | 14.61 | 669.80K |
| Sep 23, 2026 | 15.55 | 15.83 | 14.53 | 14.97 | 574.00K |
| Sep 22, 2026 | 14.00 | 16.49 | 14.00 | 15.79 | 1.14M |
| Sep 21, 2026 | 13.96 | 14.13 | 13.71 | 13.97 | 373.40K |
About ClearPoint Neuro
ClearPoint Neuro (CLPT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SOLANA BEACH, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1285550.
CLPT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Joseph Burnett | CEO and President | Sep 3, 2026 |
| Lynnette C Fallon | Director | May 26, 2026 |
| R John Fletcher | Director | Jul 6, 2026 |
| Pascal E R Girin | Director | May 21, 2026 |
| B Kristine Johnson | Director | May 26, 2026 |
| Matthew B. Klein | Director | May 26, 2026 |
| Linda M. Liau | Director | May 26, 2026 |
| Timothy T. Richards | Director | Jul 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joseph Burnett | CEO and President | Sep 3, 2026 |
| Danilo D'Alessandro | Chief Financial Officer | Jul 2, 2026 |
| Mazin Sabra | Chief Operating Officer | Mar 16, 2026 |
| L. Jeremy Stigall | Chief Business Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 29, 2026 | Joseph Burnett | Sale | 20,000 | $19.38 |
| Jun 29, 2026 | Joseph Burnett | Sale | 20,000 | $19.38 |
| Jun 29, 2026 | Joseph Burnett | Sale | 20,000 | $19.38 |
| Jun 29, 2026 | Joseph Burnett | Sale | 20,000 | $19.38 |
| Jun 17, 2026 | Joseph Burnett | Sale | 1,843 | $17.94 |
| Jun 17, 2026 | Joseph Burnett | Sale | 60,000 | $17.79 |
| Jun 17, 2026 | Joseph Burnett | Sale | 1,843 | $17.94 |
| Jun 17, 2026 | Joseph Burnett | Sale | 60,000 | $17.79 |
| Jun 17, 2026 | Joseph Burnett | Sale | 1,843 | $17.94 |
| Jun 17, 2026 | Joseph Burnett | Sale | 60,000 | $17.79 |
| Jun 17, 2026 | Joseph Burnett | Sale | 1,843 | $17.94 |
| Jun 17, 2026 | Joseph Burnett | Sale | 60,000 | $17.79 |
| Jun 1, 2026 | Timothy T. Richards | Sale | 5,415 | $12.17 |
| Jun 1, 2026 | Timothy T. Richards | Sale | 5,415 | $12.17 |
| Jun 1, 2026 | Timothy T. Richards | Sale | 5,415 | $12.17 |
CLPT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $36.97M | $-25.54M | -0.90 | $-23.93M |
| Dec 31, 2024 | $31.39M | $-18.91M | -0.70 | $-8.95M |
| Dec 31, 2023 | $23.95M | $-22.09M | -0.90 | $-13.72M |
| Dec 31, 2022 | $20.55M | $-16.43M | -0.68 | $-16.17M |
| Dec 31, 2021 | — | $-14.41M | -0.69 | $-12.70M |
Latest balance sheet: total assets $86.74M, total liabilities $75.97M, cash $29.36M (as of Jun 30, 2026).
CLPT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $15.38 |
| May 13, 2026 | 8-K Item 2.02 (results) | $12.19 |
| Mar 17, 2026 | 8-K Item 2.02 (results) | $11.16 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $15.65 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $18.23 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $10.54 |
| May 13, 2025 | 8-K Item 2.02 (results) | $14.20 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $17.22 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $13.42 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CLPT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.